Spironolactone is aldosterone antagonist drug belonging to the category of potassium sparing diuretics administered orally that has absolute bioavailability of only 68% due to the poor aqueous solubility. The main aim of the present work was to develop a self emulsifying drug delivery system (SEDDS) to enhance the oral absorption of spironolactone. The solubility of spironolactone in various oils, surfactants, and co surfactants was determined. Pseudo ternary phase diagrams were constructed using castor oil, Tween 80, and polyethylene glycol 400, and distilled water to identify the efficient self-micro emulsion region. Prepared self emulsifying drug delivery system was further evaluated for its emulsification time, drug content, optical clarity, droplet size, zeta potential, in vitro drug release. The results showed that 96.16% drug was released from the SEDDS formulation in 3 hrs. This demonstrated an enhancement in the drug release and thereby, absorption of the drug through the membrane, this was significantly higher than that of the plain drug suspension. Thus, the above findings support that the utility of SEDDS to enhance solubility and dissolution of poorly water soluble compounds which may result in improved Therapeutic performance.
INTRODUCTION
pironolactone is a specific pharmacologic antagonist of aldosterone, acting primarily through competitive binding of receptors at the aldosterone dependent sodium-potassium exchange site in the distal convoluted renal tubule. Spironolactone causes increased amounts of sodium and water be excreted, while potassium is retained (1) .
Spironolactone acts both as a diuretic and as an antihypertensive agent. Approximately, 40% of the new drug candidates in development today are water insoluble and associated with poor bioavailability (2) . There were various formulation approaches reported to overcome these problems; these include the use of drug nanoparticles, solid dispersions, micronization, lipids, surfactants, complexation with cyclodextrin, and permeation enhancers . Majority of these approaches have their limitations because of the need for specialized equipment, complicated manufacturing process, longer processing time, and regulatory complexity (2, 3) . Lipidbased formulation approaches, particularly the selfemulsifying drug delivery system (SEDDS), are well known for their potential as alternative approach for delivery of hydrophobic drugs (4, 5) .
The main objective of the study is to increase oral bioavailability of spironolactone using a lipid-based formulation i.e, self emulsifying drug delivery system. In the present work it is proposed to formulate and evaluate self emulsifying drug delivery system of spironolactone in order to achieve a better dissolution rate and preventing the drugfrom first pass metabolism which would further help in enhancing oral bioavailability
MATERIALS
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METHOD
Solubility studies: -The objective of solubility studies is to determine the solubilization capacity for drug in given vehicles.Solubility of spironolactone was estimated in different vehicles by excess solute method and % transmittance.
Screening of surfactants for emulsifying ability -
Screening of surfactant for emulsifying ability was done by %transmission studies.
Screening of co surfactants -Screening of co surfactant for emulsifying ability was done by %transmission studies
Selection of ratio of Components by Construction of
Pseudo-ternary Phase Diagram -The pseudo-ternary phase diagrams are shown in fig. 1.1 to fig. 1.3 . Three sides of the triangle represent the three components and the shaded area in the plot represents the microemulsion region. selection of component by using sigma plot software 11.0 version. 
